CYRA SMITH: Open Payments
NPI 1295552099 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 37 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $148 |
| Merck Sharp & Dohme LLC | 6 | $103 |
| Novo Nordisk Inc | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Amgen Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| ENDOTRONIX, INC. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GENZYME CORPORATION | 1 | $19 |
Products named: CAMZYOS, VERQUVO, Wegovy, ONPATTRO, ELIQUIS, Kerendia, REPATHA, FARXIGA.
Industry payments across KS — which companies pay providers there.
